Total Payments
$5,607
2024 Payments
$506.96
Companies
41
Transactions
171
Medicare Patients
5,762
Medicare Billing
$873,772
Payment Breakdown by Category
Food & Beverage$5,529 (98.6%)
Education$77.66 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,529 | 168 | 98.6% |
| Education | $77.66 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $767.01 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $418.49 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $367.51 | 11 | $0 (2024) |
| Esperion Therapeutics, Inc. | $331.50 | 9 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $311.52 | 2 | $0 (2022) |
| ABIOMED | $304.63 | 3 | $0 (2024) |
| Stryker Corporation | $281.21 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $277.12 | 11 | $0 (2022) |
| Bausch Health US, LLC | $266.22 | 17 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $255.28 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $506.96 | 13 | ABIOMED ($182.35) |
| 2023 | $1,503 | 30 | GlaxoSmithKline, LLC. ($376.17) |
| 2022 | $799.62 | 28 | Neurocrine Biosciences, Inc. ($311.52) |
| 2021 | $860.44 | 36 | GlaxoSmithKline, LLC. ($172.79) |
| 2020 | $328.79 | 14 | Esperion Therapeutics, Inc. ($153.09) |
| 2019 | $736.42 | 11 | Stryker Corporation ($142.86) |
| 2018 | $372.81 | 18 | Stryker Corporation ($138.35) |
| 2017 | $498.56 | 21 | Novartis Pharmaceuticals Corporation ($168.47) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $165.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Oncology | ||||||
| 05/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Oncology | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Respiratory | ||||||
| 04/02/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/15/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Hepatitis B Vaccine | ||||||
| 03/15/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Hepatitis B Vaccine | ||||||
| 02/29/2024 | QAPEL MEDICAL INC | — | Food and Beverage | Cash or cash equivalent | $147.27 | General |
| 02/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.50 | General |
| 11/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Diabetes | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $123.48 | General |
| 08/11/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Bone Health | ||||||
| 07/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 07/12/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/23/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $113.44 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/23/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $113.44 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/02/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Diabetes | ||||||
| 05/31/2023 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $100.01 | General |
| Category: AVVIGO_IC | ||||||
| 05/18/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $120.27 | General |
| 05/16/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $12.58 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,678 | 3,306 | $712,350 | $252,190 |
| 2022 | 27 | 1,583 | 3,093 | $703,550 | $234,387 |
| 2021 | 25 | 1,345 | 2,596 | $630,775 | $205,672 |
| 2020 | 25 | 1,156 | 2,314 | $545,750 | $181,522 |
Total Patients
5,762
Total Services
11,309
Medicare Billing
$873,772
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 160 | 609 | $152,250 | $42,161 | 27.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 58 | 469 | $93,800 | $30,879 | 32.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 133 | 413 | $41,300 | $21,343 | 51.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 109 | 195 | $68,250 | $20,300 | 29.7% |
| 99424 | Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | Office | 2023 | 115 | 265 | $39,750 | $18,395 | 46.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 125 | 141 | $42,300 | $16,050 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 196 | $49,000 | $14,900 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 137 | $47,950 | $14,465 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 87 | 89 | $44,500 | $13,458 | 30.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 107 | 121 | $30,250 | $12,200 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 83 | 83 | $20,750 | $12,079 | 58.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 53 | 59 | $20,650 | $9,439 | 45.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 60 | 61 | $9,150 | $4,343 | 47.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 59 | 99 | $9,900 | $4,292 | 43.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 55 | 56 | $8,400 | $3,809 | 45.3% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 28 | 31 | $6,200 | $3,576 | 57.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 21 | $6,300 | $3,366 | 53.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 20 | $6,000 | $1,884 | 31.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 80 | 80 | $4,000 | $1,705 | 42.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $2,800 | $1,007 | 36.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 91 | $4,550 | $764.40 | 16.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 15 | $2,250 | $674.05 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $900.00 | $611.46 | 67.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $1,150 | $490.13 | 42.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 76 | 642 | $128,400 | $39,077 | 30.4% |
About Dr. Amit Agarwal, MD
Dr. Amit Agarwal, MD is a Internal Medicine healthcare provider based in Paramus, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427097211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Agarwal, MD has received a total of $5,607 in payments from pharmaceutical and medical device companies, with $506.96 received in 2024. These payments were reported across 171 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,529).
As a Medicare-enrolled provider, Agarwal has provided services to 5,762 Medicare beneficiaries, totaling 11,309 services with total Medicare billing of $873,772. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Paramus, NJ
- Active Since 06/06/2006
- Last Updated 02/10/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427097211
Products in Payments
- FARXIGA (Drug) $338.82
- INGREZZA (Drug) $311.52
- Impella (Device) $304.63
- ENTRESTO (Drug) $277.12
- NUPLAZID (Drug) $255.28
- NEXLIZET (Drug) $226.11
- INVOKANA (Drug) $219.33
- ANORO ELLIPTA (Drug) $200.37
- APLENZIN (Drug) $198.31
- XARELTO (Drug) $193.14
- ELIQUIS (Drug) $166.68
- UBRELVY (Drug) $152.28
- MAKO (Device) $142.86
- TRIATHLON (Device) $138.35
- QUVIVIQ (Drug) $125.00
- ANORO (Drug) $118.24
- Cologuard Collection Kit (Device) $118.03
- Epclusa (Drug) $107.63
- NEXLETOL (Drug) $105.39
- Victoza (Drug) $104.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Paramus
Advay Bhatt, M.d, M.D
Internal Medicine — Payments: $54,784
Internal Medicine $54,784
Dr. Eleonora Teplinsky, M.d, M.D
Internal Medicine — Payments: $33,868
Internal Medicine $33,868
Radu Kramer, Md, MD
Internal Medicine — Payments: $27,909
Internal Medicine $27,909
Dr. Peter Luongo, M.d, M.D
Internal Medicine — Payments: $14,421
Internal Medicine $14,421
Dr. Theodore Sgambati, M.d, M.D
Internal Medicine — Payments: $9,490
Internal Medicine $9,490
Dr. Ara Manougian, M.d, M.D
Internal Medicine — Payments: $7,933
Internal Medicine $7,933